VA
VR Adviser Portfolio holdings
AUM
$1.33B
This Quarter Return
+18.72%
1 Year Return
+6.92%
3 Year Return
+862.77%
5 Year Return
+1,580.48%
10 Year Return
–
AUM
$512M
AUM Growth
+$512M
(-14%)
Cap. Flow
-$23M
Cap. Flow
% of AUM
-4.49%
Top 10 Holdings %
Top 10 Hldgs %
73.66%
Holding
32
New
4
Increased
5
Reduced
2
Closed
7
Top Buys
| 1 |
Enliven Therapeutics
ELVN
|
$48.5M |
| 2 |
AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
|
$29.4M |
| 3 |
Pliant Therapeutics
PLRX
|
$9.31M |
| 4 |
Cogent Biosciences
COGT
|
$9.14M |
| 5 |
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
|
$6.84M |
Top Sells
| 1 |
Axsome Therapeutics
AXSM
|
$51.7M |
| 2 |
Aclaris Therapeutics
ACRS
|
$28.5M |
| 3 |
Novavax
NVAX
|
$19.3M |
| 4 |
PRVB
Provention Bio, Inc. Common Stock
PRVB
|
$11.8M |
| 5 |
LIAN
LianBio American Depositary Shares
LIAN
|
$7.86M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Viridian Therapeutics
VRDN
$1.5B
| $68.7M | 13.41% | 2,699,865 | – | – |
|
|
2
Cogent Biosciences
COGT
$1.69B
| $52.7M | 10.29% | 4,884,977 +846,860 | +21% | +$9.14M |
|
|
3
Enliven Therapeutics
ELVN
$1.2B
| $48.5M | 9.47% | +2,214,142 | New | +$48.5M |
|
4
Terns Pharmaceuticals
TERN
$609M
| $42.9M | 8.37% | 3,619,522 -88,369 | -2% | -$1.05M |
|
|
5
Pliant Therapeutics
PLRX
$101M
| $38M | 7.43% | 1,430,000 +350,000 | +32% | +$9.31M |
|
|
AMAM
6
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $29.4M | 5.74% | +3,298,577 | New | +$29.4M |
|
7
GH Research
GHRS
$837M
| $28.1M | 5.49% | 3,517,125 | – | – |
|
|
DICE
8
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $23.5M | 4.58% | 819,000 | – | – |
|
9
KalVista Pharmaceuticals
KALV
$678M
| $22.9M | 4.48% | 2,916,667 | – | – |
|
10
Merus
MRUS
$4.98B
| $22.6M | 4.41% | 1,226,214 | – | – |
|
11
Celcuity
CELC
$2.17B
| $21.6M | 4.21% | 2,105,386 | – | – |
|
|
JBIO
12
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $16.8M | 3.28% | 833,927 +86,058 | +12% | +$1.74M |
|
13
Cabaletta Bio
CABA
$133M
| $16.3M | 3.19% | 1,973,251 +77,966 | +4% | +$645K |
|
|
VECT
14
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $15.9M | 3.1% | 1,866,000 | – | – |
|
15
Annexon
ANNX
$226M
| $12.4M | 2.42% | 3,220,050 | – | – |
|
16
Savara
SVRA
$567M
| $12.4M | 2.42% | 6,351,531 | – | – |
|
17
Milestone Pharmaceuticals
MIST
$156M
| $8.7M | 1.7% | 2,208,812 | – | – |
|
|
18
Aclaris Therapeutics
ACRS
$209M
| $8.42M | 1.64% | 1,040,754 -3,523,208 | -77% | -$28.5M |
|
|
THRX
19
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $6.84M | 1.34% | +770,000 | New | +$6.84M |
|
20
Trevi Therapeutics
TRVI
$883M
| $5.64M | 1.1% | 3,050,022 | – | – |
|
21
Fulcrum Therapeutics
FULC
$351M
| $3.73M | 0.73% | 1,307,094 +859,768 | +192% | +$2.45M |
|
22
Lyra Therapeutics
LYRA
$11.5M
| $1.86M | 0.36% | 924,170 | – | – |
|
23
Avalo Therapeutics
AVTX
$122M
| $1.75M | 0.34% | +1,000,000 | New | +$1.75M |
|
24
Rallybio
RLYB
$22.4M
| $1.53M | 0.3% | 268,532 | – | – |
|
|
AFMD
25
DELISTED
Affimed
AFMD
| $1.07M | 0.21% | 1,428,571 | – | – |
|